In evaluating an investment in our common stock, investors should consider carefully, among other things, the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K filed with the SEC for the year ended December 31, 2021, as well as the information contained in this Quarterly Report and our other reports and registration statements filed with the SEC.
−Removed: The Smiths Medical acquisition completed in the period has resulted in organizational changes and significant growth to our business.
+Added: The Smiths Medical acquisition completed in January 2022 has resulted in organizational changes and significant growth to our business.
If we fail to effectively manage this growth and change to our business in a manner that preserves our reputation with customers and the key aspects of our corporate culture, our business, financial condition and results of operations could be harmed.
−Removed: The Smiths Medical acquisition has resulted in significant growth in our personnel and operations, adding approximately 6,700 employees to our headcount, bringing our total headcount as of June 30, 2022 to approximately 15,300 employees.
+Added: The Smiths Medical acquisition has resulted in significant growth in our personnel and operations, adding approximately 6,700 employees to our headcount, bringing our total headcount as of September 30, 2022 to approximately 15,300 employees.
We will continue to incur significant expenditures and the allocation of management time to assimilate the Smiths Medical employees in a manner that preserves the key aspects of our corporate culture, including a focus on strong customer satisfaction, but there can be no assurance that we will be successful in our efforts.
17 unchanged sentences
Because of the significance of the Smiths Medical business acquisition to us, our failure to successfully integrate the Smiths Medical business with that of our own could have a material adverse impact on our business, financial condition and results of operations.
+Added: Prolonged periods of inflation as a result of the current Global Macroeconomic and Geopolitical Conditions could have a material adverse effect on our results of operations.
+Added: Global supply chain disruptions as a result of COVID-19 and more recently the war in the Ukraine has resulted in, and may continue to result in, higher interest rates and capital costs, increased raw material costs, higher shipping costs, and the negative impacts from weakening foreign exchange rates.
+Added: We have experienced and may continue to experience these inflationary increases in our manufacturing costs and operating expenses as well as negative impacts on our operating results from weakening exchange rates.
+Added: Prolonged inflation may also reduce or delay orders for our products and for certain products we may be unable to satisfy demand, both of which could have a material adverse impact on our sales and results of operations.
There have been no other material changes in the risk factors other than those mentioned above from those previously disclosed under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K with the SEC for the year ended December 31, 2021.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.